OBI — Ondine Biomedical Share News
0.000.00%
- £41.00m
- £40.53m
- CA$1.20m
REG - Ondine Biomedical - Close of Bookbuild
AnnouncementREG - Ondine Biomedical - Update. Re investor-led financing
AnnouncementREG - Ondine Biomedical - Ondine announces investor-led financing
AnnouncementREG - Ondine Biomedical - Photodisinfection recommended as Standard of Care
AnnouncementRCS - Ondine Biomedical - Steriwave use expanded following successful pilot
AnnouncementRCS - Ondine Biomedical - 66.5% reduction in spine surgery infection rate
AnnouncementRCS - Ondine Biomedical - Steriwave shown to reduce resistant bacteria
AnnouncementRCS - Ondine Biomedical - Steriwave now in Canada's East Coast
AnnouncementRCS - Ondine Biomedical - Ondine to present poster at IP2023, Liverpool
AnnouncementRCS - Ondine Biomedical - Hospital to adopt Steriwave as standard-of-care
AnnouncementRCS - Ondine Biomedical - Burnaby Hospital deploys Steriwave
AnnouncementREG - Ondine Biomedical - Half-year Report
AnnouncementRCS - Ondine Biomedical - Montreal Heart Institute pilots Steriwave
AnnouncementRCS - Ondine Biomedical - Steriwave proven effective against XDR bacteria
AnnouncementRCS - Ondine Biomedical - Steriwave evaluation at major heart institute
AnnouncementREG - Ondine Biomedical - Notice of Results and Investor Presentation
AnnouncementRCS - Ondine Biomedical - Ondine to present new AMR research at ICPIC Geneva
AnnouncementREG - AIM - AIM Notice - 23/08/2023
AnnouncementREG - Ondine Biomedical - Issue of Equity and TVR
Announcement